A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.
Nurse Mpho Matloane prepares a syringe filled with the drug Lenacapavir which he prepares to administer to Kegoratile Aphane (left) at the Phedisong clinic in Ga-Rankuwa, north-west of Pretoria, on Dec. 2, 2025.
Ihsaan Haffe/AFP via Getty Images
hide caption
toggle caption
Ihsaan Haffe/AFP via Getty Images
South African officially launches twice-yearly Lenacapavir HIV prevention jab
PICS: Ramaphosa launches Lenacapavir rollout, says it offers 'hope' in fight against HIV/AIDS
WATCH | Ramaphosa launches rollout of new HIV prevention injection Lenacapavir
Ramaphosa urged to press for wider access to Gilead’s HIV shot in SA
WATCH LIVE | Lenacapavir rollout launch
Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa
How to use the anti-HIV jab — and where to find it
Sudáfrica califica la distribución del medicamento lenacapavir como un "punto de inflexión" frente al VIH
On 5 June, South Africa is about to begin one of its most important HIV prevention drives in decades. The country will start to…
Lenacapavir has been administered since Monday in South Africa, Eswatini and Zambia. This is the first time this promising…
South Africa officially launched the national rollout of Lenacapavir, a groundbreaking, twice-yearly injectable drug for HIV…
President Cyril Ramaphosa has launched South Africa’s rollout of Lenacapavir, a twice-yearly HIV prevention injection aimed at…
Targeting men who move around for work is crucial for the success of a new HIV/Aids treatment.
The drug - a twice-yearly injection – reduces the current HIV treatment cost in developing countries.
